What Is Stevens-Johnson Syndrome?
Stevens-Johnson Syndrome (SJS) is a rare, serious reaction, most often to a medication, in which the skin and mucous membranes blister and peel. It is a medical emergency, and when a drug is the cause, it can also be the basis of a product liability claim.
- SJS is usually triggered by a medication taken in the previous four weeks.
- It typically starts with fever and flu-like symptoms before any rash appears.
- The skin blisters and sheds in a way that resembles a severe burn.
- Survivors often live with permanent eye, skin, and mucous membrane damage.
Anyone showing these signs after starting a new drug should be treated as a medical emergency first and a legal question second.
If you are searching “what is SJS,” you are probably looking at a hospital discharge summary, a frightening rash, or a word a doctor used quickly and did not explain. Stevens-Johnson Syndrome is a severe reaction involving the skin and mucous membranes, and in the great majority of cases, a medication triggers it. This guide walks through what the condition is, how it behaves, what it leaves behind, and the point at which it stops being only a medical story and becomes a legal one.
Greg Jones Law is a law firm rather than a medical provider, so nothing here is treatment advice. What we can offer is what we have learned from years of representing SJS and toxic epidermal necrolysis clients and reading their records closely.
Key Takeaways about What is Stevens-Johnson Syndrome
- Stevens-Johnson Syndrome is a rare, severe reaction affecting the skin and mucous membranes, usually triggered by a medication.
- SJS and toxic epidermal necrolysis sit on the same disease spectrum and are separated by how much of the body surface detaches.
- The reaction typically begins four to 28 days after the causing drug is taken and starts with flu-like symptoms rather than a rash.
- Long-term effects frequently involve the eyes, skin pigmentation, and mucous membranes, and can last for life.
- When a drug manufacturer failed to warn adequately about the risk, survivors may have grounds for a product liability claim.
What Causes Stevens-Johnson Syndrome?
Medications cause the large majority of cases, though infections account for a meaningful minority. A systematic review of published cases found that roughly nine in 10 were attributed to a drug, with antibiotics the most frequently reported class, followed by anticonvulsants.
The drug groups that come up repeatedly in the medical literature include sulfa antibiotics, anticonvulsants such as carbamazepine and phenytoin, the gout medication allopurinol, and certain nonsteroidal anti-inflammatory drugs. These are ordinary prescriptions, which is part of what makes the condition so difficult for families to absorb.
Not every case traces back to a pill. Infections, particularly Mycoplasma pneumoniae, are well-documented triggers, and in a share of cases no cause is ever identified. If you want details on the drugs that most often cause SJS, that is where the pharmacology sits.
SJS vs. TEN: What Is the Difference?
The difference is how much skin detaches, and the two conditions are now understood as two ends of a single spectrum rather than separate diseases. Doctors use body surface area as the dividing line.
- Stevens-Johnson Syndrome: skin detachment affecting less than 10 percent of the body surface.
- SJS and TEN overlap: detachment affecting 10 to 30 percent of the body surface.
- Toxic epidermal necrolysis (TEN): detachment affecting more than 30 percent of the body surface.
Those thresholds come from the National Institutes of Health, and all forms are treated as a medical emergency. For legal purposes, the distinction matters less than people expect, because the same product liability principles apply across the spectrum. What changes is the severity of the harm, and therefore the scale of what a survivor has lost.
How the Reaction Typically Unfolds
SJS rarely announces itself. It usually opens with fever, sore throat, burning eyes, and body aches, which is why so many people are sent home with a diagnosis of flu on the first visit.
The rash follows one to three days later. Flat red or purplish spots appear, often starting on the face and chest, then spread and merge before blistering and shedding the top layer of skin. The reaction also attacks mucous membranes, so the mouth, eyes, and genitals are frequently involved.
Timing is the detail that matters most to a later legal analysis. Reactions generally begin between four and 28 days after the causing medication is started, and that window is what connects a specific drug to a specific injury. Recognizing the early warning signs of SJS is what gets someone to an emergency department before the detachment spreads.
Who Is Most at Risk?
Anyone can develop SJS, but certain groups carry a higher risk, and some of it is written into a person's genetics. Variations in a gene called HLA-B are strongly associated with the condition, and specific variants are linked to reactions to particular drugs.
People living with HIV, those with weakened immune systems, and people with a personal or family history of the reaction also face elevated risk. Genetic screening before prescribing certain anticonvulsants is recommended in some patient populations for exactly this reason.
That last point carries weight in litigation. Where a known screening test existed, and a risk was documented, the question of what a manufacturer told prescribers becomes a live one.
What SJS Leaves Behind
Recovery from the acute phase is not the end of the story for most survivors. The lasting effects tend to cluster in the eyes, the skin, and the mucous membranes.
- Eyes: chronic dryness, inflammation, light sensitivity, scarring of the ocular surface, and vision impairment.
- Skin: permanent changes in pigmentation, dryness, fragility, and scarring across large areas.
- Hair and nails: hair loss and abnormal nail growth or loss.
- Other systems: altered taste, difficulty urinating, and genital changes.
Families are often surprised that the hardest part arrives after discharge. Long-term ophthalmology care, repeated procedures, and the practical cost of living with damaged vision are usually the largest items in any honest accounting of what the reaction took.
When Stevens-Johnson Syndrome Becomes a Legal Matter
A drug reaction becomes a legal claim when a company knew or should have known that its product could cause it and failed to warn clearly. That is the dividing line, and it is why medical publishers can describe the condition but cannot answer this part of the question.
Three facts tend to matter most when we evaluate a case. The first is which drug was taken and when, the second is what the label said at that time, and the third is what the medical records show about the timing of the reaction.
None of that requires you to have answers before you call. If you are trying to work out when SJS becomes a legal claim, we can walk through it with you at no cost. Our published settlements in SJS and TEN matters have ranged from $1.25 million to $8 million, each confidential, and prior results do not predict the outcome of any other claim.
FAQs about What Is Stevens-Johnson Syndrome
These are the questions patients and families ask us most often after a diagnosis, beyond the ground already covered above.
Is Stevens-Johnson syndrome contagious?
No. SJS is an immune reaction within one person's own body, not an infection that passes between people. Family members and caregivers are not at risk from contact, though the person affected is vulnerable to infection because the skin barrier is damaged.
Why do some people spell it Stephen Johnson syndrome or Steven Johnson's syndrome?
Because it is named after two physicians, Albert Stevens and Frank Johnson, who described it in 1922, and the spelling is easy to mishear. The correct form is Stevens-Johnson Syndrome, and the common misspellings all refer to the same condition.
Can Stevens-Johnson syndrome happen more than once?
Yes, and that is why identifying the trigger matters so much. Someone who has had the reaction is generally advised to permanently avoid the drug that caused it and closely related medications, which is a decision for their treating physician.
How is SJS diagnosed?
Diagnosis is based on the clinical picture and the person's medication history, sometimes supported by a skin biopsy. There is no single universal test, which is one reason the cause is often identified weeks after the hospitalization.
Do children get Stevens-Johnson syndrome?
Yes. Children can develop SJS from the same medication classes that affect adults, and pediatric cases are among the most difficult we see because the long-term eye and skin consequences run for a lifetime.
Does a recovery from SJS mean symptoms are gone for good?
Not usually. Many survivors describe ongoing eye dryness and light sensitivity, skin changes, and fatigue long after the acute phase ends, and ongoing specialty care is common.
Talk With Someone Who Knows What SJS Does to a Life
If a medication caused this reaction in you or someone you love, you deserve a clear answer about whether a claim exists. You should not have to work that out alone while you are still in follow-up appointments.
Call Greg Jones Law at (855) 566-3752 or request a free case review. We answer around the clock, and there is no fee unless we recover compensation for you.
Greg Jones is licensed in North Carolina, South Carolina, Georgia, and Texas, and associates with attorneys in other jurisdictions as needed.
Greg Jones
Founder
Greg Jones is the founder of Greg Jones Law, P.A. and is licensed to practice law in North Carolina, South Carolina, Georgia and Texas. He has offices in both North Carolina and Puerto Rico often associating with other top trial lawyers across the nation in order to get his clients the best representation possible.
He focuses his practice on plaintiff personal injury litigation involving product liability claims against pharmaceuticals and medical device manufacturers. He is an active member in a number of local, state and national trial lawyers associations and frequently travels to conferences and lectures, where he consults with other attorneys regarding personal injury representation.
Author's Bio